Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Plos One|December 14, 2020
Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolizationWon Sohn, Cheol Bae Ham, Nam Hee Kim, et al.
Clinical and Molecular Hepatology|October 18, 2013
Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, KoreaEun Haeng Jeong, Dae Won Jun, Yong Kyun Cho, et al.
The American Journal of Gastroenterology|October 25, 2018
Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort StudyHyun-Suk Jung, Yoosoo Chang, Min-Jung Kwon, et al.
Digestive Diseases and Sciences|September 15, 2012
Clinical impact of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with biliary tract infectionHong Joo Kim, Jung Ho Park, Dong Il Park, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 17, 2009
Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approachHyung Ook Kim, Seung Kwon Kim, Byung Ho Son, et al.
World Journal of Gastroenterology|September 23, 2008
Metabolic syndrome is associated with erosive esophagitisJung-Ho Park, Dong-Il Park, Hong-Joo Kim, et al.
Journal of Gastroenterology and Hepatology|July 28, 2010
Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapyHong Joo Kim, Jung Ho Park, Dong Il Park, et al.
Gut and Liver|May 1, 2010
Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin ResistanceHong Joo Kim, Jung Ho Park, Dong Il Park, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2010
Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis BHong Joo Kim, Dong Il Park, Jung Ho Park, et al.
Hepatology (Baltimore, Md.)|July 19, 2018
Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort StudyYoosoo Chang, Yong Kyun Cho, Yejin Kim, et al.
Pageof 24